Morgan Stanley raised the firm’s price target on Universal Health (UHS) to $233 from $200 and keeps an Equal Weight rating on the shares. Valuation is “undemanding,” but an uptick in admissions volume, especially in the behavioral segment, is likely needed to drive a more meaningful re-rating, the analyst contends.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health: Balanced Outlook Amid MSPP Gains and Medicaid Challenges
- Universal Health price target raised to $253 from $227 at Guggenheim
- Universal Health Services Reports Strong Q3 2025 Results
- UHS Earnings Call: Mixed Outlook with Strong EPS Growth
- Universal Health Services: Strong Growth and Strategic Expansion Drive Buy Rating with $251 Price Target